Skip to main content

Table 8 Stomach cancer; meta-analysis results

From: Systematic review of the relation between smokeless tobacco and cancer in Europe and North America

    

Heterogeneity

Type of ST (region)a

Adjustments/restrictionsb

Number of estimates (RR/OR ids)c

Random-effects RR/OR (95% CI)

χ2

I2

P(χ2)

Any

Overall data

9 (1, 6, 9, 10, 14, 15, 17, 19, 21)

1.03 (0.90–1.19)

10.5

24.0

0.230

 

Smoking-adjusted

8 (1, 6, 9, 10, 14, 17, 19, 21)

1.03 (0.88–1.20)

10.3

31.9

0.173

 

Never smokers

4 (2, 6, 11, 20)

1.27 (0.75–2.13)

7.0

57.2

0.072

Any (USA)

Overall data

4 (1, 6, 14, 15)

1.41 (0.95–2.10)

0.1

0.0

0.988

 

Smoking-adjusted

3 (1, 6, 14)

1.41 (0.93–2.12)

0.1

0.0

0.942

 

Never smokers

2 (2, 6)

1.96 (0.82–4.70)

1.6

38.2

0.203

Snuff (Scandinavia)

Overall data

5 (9, 10, 17, 19, 21)

0.98 (0.82–1.17)

8.1

50.4

0.089

 

Smoking-adjusted

5 (9, 10, 17, 19, 21)

0.98 (0.82–1.17)

8.1

50.4

0.089

 

Never smokers

2 (11, 20)

0.90 (0.35–2.30)

4.2

76.4

0.040

  1. a For each study/sex, the RR/OR for ST from Table 7 was included if available, otherwise that for chewing tobacco or snuff was used.
  2. b Smoking-adjusted includes estimates for smokers and non-smokers combined, adjusted for smoking if available, and estimates for never smokers otherwise.
  3. c The actual estimates included are identified by their RR/OR identification numbers as given in Table 7.
  4. CI = confidence interval; ST = smokeless tobacco; OR = odds ratio; RR = relative risk.